Stock Analysis

EssilorLuxottica Société anonyme First Half 2024 Earnings: EPS: €3.02 (vs €3.06 in 1H 2023)

ENXTPA:EL
Source: Shutterstock

EssilorLuxottica Société anonyme (EPA:EL) First Half 2024 Results

Key Financial Results

  • Revenue: €13.3b (up 3.4% from 1H 2023).
  • Net income: €1.37b (flat on 1H 2023).
  • Profit margin: 10% (in line with 1H 2023).
  • EPS: €3.02.
earnings-and-revenue-growth
ENXTPA:EL Earnings and Revenue Growth July 31st 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

EssilorLuxottica Société anonyme Earnings Insights

Looking ahead, revenue is forecast to grow 5.8% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Medical Equipment industry in France.

Performance of the French Medical Equipment industry.

The company's shares are up 7.7% from a week ago.

Valuation

It's possible that EssilorLuxottica Société anonyme could be overvalued with our 6-factor valuation analysis indicating potential weakness. To access our thorough examination of analyst consensus click here and discover the expected future direction of the company.

Valuation is complex, but we're here to simplify it.

Discover if EssilorLuxottica Société anonyme might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.